Abiomed Inc (NASDAQ:ABMD)

60.79
Delayed Data
As of Feb 27
 -0.21 / -0.34%
Today’s Change
20.29
Today|||52-Week Range
61.94
+59.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$2.5B

Company Description

ABIOMED, Inc. Manufactures cardiac support, recovery, and replacement devices. The company provides mechanical circulatory support devices and continuum of care to heart failure patients. It also develop, manufacture and market proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The company products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. ABIOMED was founded in 1981 and is headquartered in Danvers, MA.

Contact Information

ABIOMED, Inc.
22 Cherry Hill Drive
Danvers Massachusetts 01923
P:(978) 646-1400
Investor Relations:
(978) 676-1590

Employees

Shareholders

Other institutional49.06%
Mutual fund holders45.92%
Individual stakeholders20.44%

Top Executives

Michael R. MinogueChairman, President & Chief Executive Officer
David M. WeberChief Operating Officer
Robert L. BowenChief Financial Officer, Treasurer & VP
Karim BenaliChief Medical Officer
Thorsten SiessChief Technology Officer

To view my watchlist

Not a member yet?

Sign up now for a free account